Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
overseas clinical trials
Research
Holoclara wriggles into ph. 1, sets sights on immune disease
The drug candidate being tested, HC002, is an oral small molecule that was originally sourced from roundworms that live in our guts.
Darren Incorvaia
Dec 18, 2024 9:05am
Health tech firm aims to expand trial access in Asia
Dec 4, 2024 9:00am
Europe’s share of the world’s clinical trials shrinks: IQVIA
Oct 23, 2024 11:48am
Tampa cancer center and Japanese CRO form trial partnership
Sep 29, 2024 6:48pm
Fujitsu partners with Paradigm to boost clinical trials in Japan
Aug 28, 2024 12:43pm
Massive Bio expands European operations with 3 new hires
Sep 28, 2022 10:48pm
